|HIV infection: epidemiology, pathogenesis, treatment, and prevention|
G Maartens, C Celum, SR Lewin
The Lancet 384 (9939), 258-271, 2014
|Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings|
G Meintjes, SD Lawn, F Scano, G Maartens, MA French, W Worodria, ...
The Lancet infectious diseases 8 (8), 516-523, 2008
|Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa|
D Coetzee, K Hildebrand, A Boulle, G Maartens, F Louis, V Labatala, ...
Aids 18 (6), 887-895, 2004
|Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of …|
H Getahun, W Kittikraisak, CM Heilig, EL Corbett, H Ayles, KP Cain, ...
PLoS medicine 8 (1), e1000391, 2011
|The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis|
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
|Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa|
JB Nachega, M Hislop, H Nguyen, DW Dowdy, RE Chaisson, ...
Journal of acquired immune deficiency syndromes (1999) 51 (1), 65, 2009
|Adherence to nonnucleoside reverse transcriptase inhibitor–based HIV therapy and virologic outcomes|
JB Nachega, M Hislop, DW Dowdy, RE Chaisson, L Regensberg, ...
Annals of internal medicine 146 (8), 564-573, 2007
|TB/HIV: a clinical manual|
AD Harries, D Maher, S Graham, C Gilks, P Nunn
World Health Organization, 2004
|Randomized placebo-controlled trial of prednisone for paradoxical TB-associated immune reconstitution inflammatory syndrome|
G Meintjes, RJ Wilkinson, C Morroni, DJ Pepper, K Rebe, MX Rangaka, ...
AIDS (London, England) 24 (15), 2381, 2010
|Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults|
G Maartens, PA Willcox, SR Benatar
The American journal of medicine 89 (3), 291-296, 1990
|Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults|
JB Nachega, M Hislop, DW Dowdy, M Lo, SB Omer, L Regensberg, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (1), 78-84, 2006
|Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects|
I Sanne, H Mommeja-Marin, J Hinkle, JA Bartlett, MM Lederman, ...
The Journal of infectious diseases 191 (6), 825-829, 2005
|Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa|
A Boulle, G Van Cutsem, K Hilderbrand, C Cragg, M Abrahams, S Mathee, ...
Aids 24 (4), 563-572, 2010
|Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome|
H McIlleron, G Meintjes, WJ Burman, G Maartens
The Journal of infectious diseases 196 (Supplement_1), S63-S75, 2007
|Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area|
M Badri, R Ehrlich, R Wood, T Pulerwitz, G Maartens
The International Journal of Tuberculosis and Lung Disease 5 (3), 225-232, 2001
|Outcomes of nevirapine-and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy|
A Boulle, G Van Cutsem, K Cohen, K Hilderbrand, S Mathee, M Abrahams, ...
Jama 300 (5), 530-539, 2008
|Effect of HIV-1 infection on T-cell–based and skin test detection of tuberculosis infection|
MX Rangaka, KA Wilkinson, R Seldon, G Van Cutsem, GA Meintjes, ...
American journal of respiratory and critical care medicine 175 (5), 514-520, 2007
|Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial|
MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, ...
The Lancet 384 (9944), 682-690, 2014
|CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment|
CB Holmes, R Wood, M Badri, S Zilber, B Wang, G Maartens, H Zheng, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (4), 464-469, 2006
|Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study|
JB Nachega, AR Knowlton, A Deluca, JH Schoeman, L Watkinson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 43, S127-S133, 2006